e MAVYRET with other medicines.
How should I take MAVYRET?
Take MAVYRET exactly as your healthcare provider tells you to take it. Do not change your dose unless your healthcare provider tells you to.
Do not stop taking MAVYRET without first talking with your healthcare provider.
Take 3 MAVYRET tablets at one time each day.
Take MAVYRET with food.
It is important that you do not miss or skip doses of MAVYRET during treatment.
If you miss a dose of MAVYRET and it is:
Less than 18 hours from the time you usually take MAVYRET, take the missed dose with food as soon as possible. Then take your next dose at your usual time.
More than 18 hours from the time you usually take MAVYRET, do not take the missed dose. Take your next dose as usual with food.
If you take too much MAVYRET, call your healthcare provider or go to the nearest hospital emergency room right away.
What are the possible side effects of MAVYRET?
MAVYRET can cause serious side effects, including:
Hepatitis B virus reactivation. See “What is the most important information I should know about MAVYRET?”
The most common side effects of MAVYRET include headache and tiredness.
These are not all the possible side effects of MAVYRET.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How should I store MAVYRET?
Store MAVYRET at or below 86°F (30°C).
Keep MAVYRET in its original blister package until you are ready to take it.
Keep MAVYRET and all medicines out of the reach of children.
General information about the safe and effective use of MAVYRET
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use MAVYRET for a condition for which it was not prescribed. Do not give MAVYRET to other people, even if they have the same symptoms that you have. It may harm them. You can ask your healthcare provider or pharmacist for information about MAVYRET that is written for health professionals.
What are the ingredients in MAVYRET?
Active ingredients: glecaprevir and pibrentasvir
Inactive ingredients: colloidal silicon dioxide, copovidone (type K 28), croscarmellose sodium, hypromellose 2910, iron oxide red, lactose monohydrate, polyethylene glycol 3350, propylene glycol monocaprylate (type II), sodium stearyl fumarate, titanium dioxide, and vitamin E (tocopherol) polyethylene glycol succinate. The tablets do not contain gluten.
Manufactured by AbbVie Inc., North Chicago, IL 60064.
MAVYRET is a trademark of AbbVie Inc. All other brands listed are trademarks of their respective owners and are not trademarks of AbbVie Inc. The makers of these brands are not affiliated with and do not endorse AbbVie Inc. or its products.
For more information go to www.MAVYRET.com or call 1-800-633-9110.
This Patient Information has been approved by the U.S. Food and Drug Administration.
Issued: August 2017
03-B632
PRINCIPAL DISPLAY PANEL
NDC 0074–2625–28
Rx only
Mavyret™
(glecaprevir and pibrentasvir)
100mg/40mg
Each tablet contains glecaprevir and pibrentasvir 100mg / 40mg
This carton contains 21 tablets packaged as follows:
7 wallets for 1 week of treatment.
Each wallet contains 3 tablets.
Do not use if seal on top of carton is broken or missing
Keep out of reach of children
Store at or below 30°C (86°F)
See Package Insert for full Prescribing Information
AbbVie Inc.
North Chicago, IL 60064
©2017 AbbVie Inc.
|
